MICHR Clinical and Translational Science Pilot Award
Funding for innovative studies addressing a common cause of inefficiency in the translational research pipeline
Who?
Faculty members with primary appointments at U-M; Michigan Medicine affiliate physicians (i.e., U-M Health West and Sparrow); and U-M staff are eligible to serve as Principal Investigators. Community partners and patient advisors are eligible to serve as Co-PIs. Preference may be given to applicants who have not previously received a MICHR CTS Pilot Award.
When?
We anticipate offering this funding opportunity annually and expect the next round to be announced in the summer of 2026. Watch this page for details.
How much?
This service is free and there are no cost-sharing requirements for your department. The pricing/recharge rates for this and other MICHR services are available here.
What is this offering?
What is this service?
The Clinical and Translational Science Pilot Award aims to support new and innovative research projects relevant to clinical & translational science (CTS). CTS is a field of investigation focused on understanding a scientific or operational principle that underlies a step of the translational process, with the goal of developing generalizable principles to accelerate translational research.
We encourage applications that propose addressing a common cause of inefficiency or failure in research projects at any stage of translation, with the goal of producing foundational knowledge that will ultimately improve health.
To learn more about CTS and this funding opportunity:
- CTS Pilot Award Webinar: View the CTS Pilot informational webinar here.
- Visit the NIH-NCATS Translational Science Resources page.
How this advances translational science
Developing innovations that address persistent challenges to advancing translational progress.
Translational Science Categories: